Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**TPT1 pseudogene 6 (TPT1P6)** refers to a *pseudogene* related to the TPT1 (tumor protein, translationally-controlled 1) locus. Pseudogenes are genomic DNA sequences similar to normal genes but are typically nonfunctional; they do not encode active proteins and are generally not considered therapeutic targets. While the parental gene TPT1 encodes a multifunctional protein involved in cellular growth, proliferation, apoptosis, and cancer[1][4][5], *TPT1P6* as a pseudogene does not have an an established protein product or direct biological function or disease association. No interacting drugs, biomarker utility, or disease roles have been described for TPT1P6 in the available literature. If the intention was to reference the active protein-coding gene involved in cellular growth and cancer, the correct target is "Tumor protein, translationally-controlled 1 (TPT1, also known as TCTP or histamine-releasing factor)" rather than the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 6 (TPT1P6).